Vir Biotechnology, Inc. Ratios

Ratios Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 93.99%90.94%96.79%98.86%
EBT Margin -2,982.87%-1,090.78%-2,157.08%-405.53%50.19%46.68%-728.93%-704.95%
EBIT Margin -3,009.49%-1,112.60%-2,199.72%-388.88%38.41%51.56%-794.04%-791.27%
EBITDA Margin -3,009.49%-1,112.60%-2,199.72%-388.88%38.41%51.56%-794.04%-791.27%
Operating Margin -3,009.49%-1,112.60%-2,199.72%-388.88%38.41%51.56%-794.04%-791.27%
Net Margin -2,579.47%-1,086.28%-2,158.98%-405.67%48.25%31.92%-713.69%-703.40%
FCF Margin -2,552.55%-958.83%-1,712.67%-258.60%-6.34%98.73%-928.71%-611.35%
Efficiency
Assets Average 351.83M715.42M1,436.51M2,378.18M2,360.57M1,658.94M
Equity Average -124.05M122.38M570.40M1,074.35M1,754.91M1,834.10M1,370.31M
Invested Capital -68.92M-179.18M436.39M727.45M1,431.85M2,077.96M1,590.24M1,166.44M
Asset Utilization Ratio 0.020.110.760.680.040.04
Leverage & Solvency
Debt to Equity 0.030.010.01
Debt Ratio 0.020.010.01
Equity Ratio -0.940.830.780.730.740.830.82
Dividends & Payouts
FCF Payout Ratio 0.00
Valuation
Enterprise Value -187.92M-98.44M995.78M2,674.61M4,914.96M999.01M-159.27M109.87M
Market Capitalization 1,379.21M3,411.47M5,479.95M3,369.16M1,353.28M1,010.87M
Return Ratios
Return on Sales -25.79%-10.86%-21.59%-4.06%0.48%0.32%-7.14%-7.03%
Return on Capital Employed -0.61%-0.48%0.38%0.45%-0.31%-0.38%
Return on Invested Capital 0.95%0.37%0.32%-0.37%-0.43%
Return on Assets -0.50%-0.43%0.37%0.22%-0.26%-0.31%
Return on Equity 0.93%-1.43%-0.54%0.49%0.29%-0.34%-0.38%